Filing Details
- Accession Number:
- 0001562180-19-002767
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-10 16:31:02
- Reporting Period:
- 2019-05-10
- Accepted Time:
- 2019-05-10 16:31:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597553 | Sage Therapeutics Inc. | SAGE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1320559 | Marie Anne Cook | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | Svp, Gc & Secretary | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-10 | 15,000 | $28.63 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-10 | 15,000 | $166.14 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-10 | 700 | $56.27 | 700 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-10 | 15,000 | $0.00 | 15,000 | $28.63 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-10 | 700 | $0.00 | 700 | $56.27 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,000 | 2026-02-08 | No | 4 | M | Direct | |
| 109,300 | 2025-09-16 | No | 4 | M | Direct |
Footnotes
- The exercises reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The securities awarded on February 8, 2016 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,000 shares of common stock vested on February 8, 2017, with 15,000 shares vesting in 36 equal monthly installments thereafter. Options to purchase 10,000 shares of common stock shall vest periodically upon the Company reaching certain milestone.
- Reflects the balance after 10,000 options were forfeited due to unmet performance condition.
- The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. 27,500 shares vested on September 16, 2016 with the remaining shares vesting in equal monthly installments over the 36 months following September 16, 2016.
Billionaire Hedge Funds
